Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JMKX001899 Drug-Drug Interaction Study
NCT06348290Phase 1Not yet recruiting
- Sponsor
- Jemincare
- Start
- Apr 2024
- Primary completion
- May 2024
- Modality
- Small Molecules
01
Overview
Phase 1, open-label trial of sosimerasib in solid tumor (3 arms), sponsored by Jemincare. Primary endpoints: Maximum Plasma Concentration, Area Under the Curve from Time 0 to Infinity and 1 more. Planned start Apr 2024; status: not yet recruiting.
02
Drugs
sosimerasib
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT06348290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06348290.